Cord blood banking
Studies estimate that one in 217 individuals will need to undergo allogeneic or autologous stem cell transplantation in his or her lifetime.1 With private cord blood banking, the individual has full access to his or her own stem cells when needed.
Find out more about more about cord blood banking today.
Blood from the umbilical cord, which connects the foetus to the placenta, allowing blood to transport oxygen and nutrition, is one of the most easily harvested sources of stem cells. This blood can be quickly and painlessly collected at birth and frozen for future medical use.
Cord blood contains a high concentration of haematopoietic stem cells ("HSCs"), which replenish blood and regenerate the immune system. The process of collecting cord blood is non-invasive and risk-free for both mother and child. Cord blood has been proven to be an effective substitute for bone marrow and can be used to support the treatment of more than 80 diseases, including leukaemia, lymphoma and thalassaemia major
.
Studies estimate that one in 217 individuals will need to undergo allogeneic or autologous stem cell transplantation in his or her lifetime.1 With private cord blood banking, the individual has full access to his or her own stem cells when needed. Furthermore, stem cells from cord blood are not only a perfect match for the baby but may also be made readily available for the child’s siblings. If a family member requires these cells, the chance of a match is as high as 75%. Survival rates also double when the patient receives stem cells from biological relatives compared to an unrelated donor.2
Scientists believe the true potential of cord blood has yet to be fully tapped and that it can also be used to treat certain neurological disorders such as autism and cerebral palsy. Notable clinical trials involving stem cells are underway for many other conditions, and researchers around the world continue to explore new avenues for cellular therapy and regenerative medicine with cord blood stem cells.
1. Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Blood and Marrow Transplantation. 2008; 14:316-322
2. Gluckman et al. Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from a HLA-identical sibling. N Engl J Med. 1989; 321:1174-1178
One of the cord blood banking pioneers in Asia with facilities accredited and/or certified by multiple gold standards. Provides cord blood banking, cord lining and cord tissue banking services.
No. 1 cord blood bank in Hong Kong accredited by multiple gold standards. Provides cord blood banking and cord tissue banking services.
Longest established and AABB accredited cord blood bank in Malaysia. Provides cord blood banking, cord lining and cord tissue banking services.